Efficiency Study for Acute Radiation-induced and Chemotherapy-induced Pulmonary Fibrosis With Bevasizumab

NCT01917877 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pulmonary Fibrosis

Interventions

DRUG: Bevacizumab
DRUG: Dexamethasone

Sponsor

Qingdao Central Hospital